Key terms
About CLLS
Cellectis SA operates as a clinical stage biotechnological company, which engages in gene-editing platform to develop cell and gene therapies. The company was founded by David J. Sourdive and André Choulika on February 20, 1999 and is headquartered in Paris, France.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest CLLS news
CLLS Financials
Key terms
Ad Feedback
CLLS Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
CLLS Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range